QUOTE AND NEWS
StreetInsider.com  May 15  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Savient+Pharmaceuticals+%28SVNT%29+Posts+Q1+Loss+of+34cShare/8339320.html for the full story.
StreetInsider.com  Mar 19  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Savient+Pharmaceuticals+%28SVNT%29+Posts+Q4+Loss+of+39cShare/8195161.html for the full story.
StreetInsider.com  Feb 19  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Sobi%2C+Savient+%28SVNT%29+Enter+Kineret+Co-Promotion+Agreement/8109751.html for the full story.
Benzinga  Jan 8  Comment 
Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) and its wholly owned subsidiary, Savient Pharma Ireland Ltd., today announced that the European Commission has granted a marketing authorization for KRYSTEXXA^® (pegloticase) for the treatment...
Benzinga  Jan 8  Comment 
Savient Pharma (NASDAQ: SVNT) announced today that David Meeker, M.D., President and Chief Executive Officer of Genzyme, a Sanofi Company, has been elected to Savient's Board of Directors, effective January 7, 2013.  In addition, Savient...
StreetInsider.com  Nov 13  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Savient+%28SVNT%29+Reports+Encouraging+Update+from+KRYSTEXXA+Phase+III+on+Gout/7868418.html for the full story.
Benzinga  Nov 13  Comment 
Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) today announced results from new post-hoc analyses of KRYSTEXXA^® (pegloticase) pivotal Phase III and open-label extension trials that reinforced the health-related quality of life (HRQOL) benefits...
Benzinga  Nov 12  Comment 
Savient Pharmaceuticals (NASDAQ: SVNT) today announced that new data from an open-label extension (OLE) study published in the Annals of the Rheumatic Diseases reinforced the safety and efficacy profile of KRYSTEXXA^® (pegloticase) treatment...
StreetInsider.com  Nov 8  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Savient+Pharmaceuticals+%28SVNT%29+Posts+Q3+Loss+of+56cShare/7856035.html for the full story.
StreetInsider.com  Oct 19  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Savient+Pharma%27s+%28SVNT%29+KRYSTEXXA+Receives+Positive+CHMP+Opinion/7805038.html for the full story.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki